4.7 Letter

A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration

Journal

KIDNEY INTERNATIONAL
Volume 102, Issue 5, Pages 1188-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2022.07.022

Keywords

-

Funding

  1. Astellas
  2. Sanofi

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available